{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:42:06Z","timestamp":1783132926588,"version":"3.54.6"},"reference-count":24,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2014,2,1]]},"DOI":"10.1185\/03007995.2013.850066","type":"journal-article","created":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T12:16:20Z","timestamp":1380543380000},"page":"163-175","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":133,"title":["Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study"],"prefix":"10.1185","volume":"30","clinical-trial-number":[{"clinical-trial-number":"nct01081834","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kaj","family":"Stenl\u00f6f","sequence":"first","affiliation":[{"name":"Clinical Trial Center, Sahlgrenska University Hospital\rGothenburgSweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Cefalu","sequence":"additional","affiliation":[{"name":"Pennington Biomedical Research Center\rBaton Rouge, LAUSA"},{"name":"LSUHSC School of Medicine\rNew Orleans, LAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Ah","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University School of Medicine\rGoyangKorea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Jodar","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital Quiron\rMadridSpain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alba","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC Raritan, NJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Edwards","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC Raritan, NJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Tong","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC Raritan, NJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Canovatchel","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC Raritan, NJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Meininger","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, LLC Raritan, NJUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2013,10,28]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0413"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.995"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-9-201105030-00336"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.3810\/hp.2013.04.1020"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Cefalu WT, Leiter LA, Yoon K-H, et al. Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. Lancet 2013;382:941-50","DOI":"10.1016\/S0140-6736(13)60683-2"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1926"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2491"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12054"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12090"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Inagaki N, Kondo K, Yoshinari T, et al. Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study. Diabetes Obes Metab 2013: published online 19 Jun 2013. doi: 10.1111\/dom.12149","DOI":"10.1111\/dom.12149"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Lavalle-Gonzalez F, Januszewicz A, Davidson J, et al. Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial. Diabetologia 2013: published online 13 Sep 2013. doi: 10.1007\/s00125-013-3039-1","DOI":"10.1007\/s00125-013-3039-1"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01558.x"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01406.x"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4205"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1998.tb00690.x"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.6.1033"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2012.66"},{"key":"CIT0018","unstructured":"Janssen Research & Development LLC. Endocrinologic and Metabolic Drugs Advisory Committee. January 10, 2013. Canagliflozin as an adjunctive treatment to diet and exercise alone or co-administered with other antihyperglycemic agents to improve glycemic control in adults with type 2 diabetes mellitus. JNJ-28431754 (Canagliflozin). NDA 204042. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/EndocrinologicandMetabolicDrugsAdvisoryCommittee\/UCM334551.pdf [last accessed 8 May 2013]"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0612"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12081"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60407-2"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0606"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1693"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01434.x"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007995.2013.850066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T03:23:21Z","timestamp":1598757801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007995.2013.850066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,28]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2,1]]}},"alternative-id":["10.1185\/03007995.2013.850066"],"URL":"https:\/\/doi.org\/10.1185\/03007995.2013.850066","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2013-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-10-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}